Independent Predictors Analysis and Model Construction of Cavitary Central Lung Cancer

NCT ID: NCT05278754

Last Updated: 2022-03-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-12

Study Completion Date

2022-08-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a retrospective, multicenter clinical study. The main goal is to identify the risk factors for cavity formation in central-type lung cancer lesions, and to construct a prediction model for cavity formation in central-type lung cancer lesions based on the above risk factors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Central Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age:older than 18 years;
2. Clinical or pathologically confirmed central lung cancer;
3. Lesions without cavities at first diagnosis of central lung cancer;
4. Performed complete laboratory and imaging research at the first diagnosis of the central lung cancer;
5. Patients with cavities formation during follow up, and the cavities were independently confirmed by at least 3 imaging experts;
6. Patients with complete medical records;

Exclusion Criteria

1. Patients suffering other malignant tumors;
2. Patients missing the imaging data;
3. Patients missing the clinical data.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The First Affiliated Hospital of Soochow University

OTHER

Sponsor Role collaborator

The Second Affiliated Hospital of Medical College of Zhejiang University

UNKNOWN

Sponsor Role collaborator

Affiliated Hospital of Xinjiang Medical University

UNKNOWN

Sponsor Role collaborator

The Central Hospital of Lishui City

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jianfei Tu, Dr

Role: CONTACT

13646782878

Jingjing Song, Dr

Role: CONTACT

13615780342

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ZJLS-KLDMIR-22004

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Survival Outcomes of Lung Cancer
NCT03647098 RECRUITING